{"id":"https://openalex.org/W2003133170","doi":"https://doi.org/10.1097/00001813-200511000-00006","title":"Structure???anti-leukemic activity relationship study of B- and D-ring modified and non-modified steroidal esters of chlorambucil??s active metabolite","display_name":"Structure???anti-leukemic activity relationship study of B- and D-ring modified and non-modified steroidal esters of chlorambucil??s active metabolite","alternate_titles":[],"publication_year":2005,"publication_date":"2005-10-12","ids":{"openalex":"https://openalex.org/W2003133170","doi":"https://doi.org/10.1097/00001813-200511000-00006","mag":"2003133170","pmid":"https://pubmed.ncbi.nlm.nih.gov/16222149"},"language":"en","primary_location":{"id":"doi:10.1097/00001813-200511000-00006","doi":"https://doi.org/10.1097/00001813-200511000-00006","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001813-200511000-00006","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2003133170"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101627088","display_name":"A. Papageorgiou","orcid":"https://orcid.org/0000-0002-3039-9257","observed_orcids":["https://orcid.org/0000-0002-3039-9257"]},"institutions":[{"id":"https://openalex.org/I174878644","display_name":"University of Patras","ror":"https://ror.org/017wvtq80","country_code":"GR","type":"education","lineage":["https://openalex.org/I174878644"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Athanasios Papageorgiou","raw_affiliation_strings":["Laboratory of Pharmaceutical Chemistry, Department of Pharmacy, University of Patras, Greece","Sponsorship: This research was supported by \u2018K. Karathedori\u2019 grant 3013, Research Committee of the University of Patras, Greece","to S. S. Nikolaropoulos, Laboratory of Pharmaceutical Chemistry, School of Health Sciences, Department of Pharmacy, University of Patras, 26500 Rion (Patras), Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmaceutical Chemistry, Department of Pharmacy, University of Patras, Greece","institution_ids":["https://openalex.org/I174878644"]},{"raw_affiliation_string":"Sponsorship: This research was supported by \u2018K. Karathedori\u2019 grant 3013, Research Committee of the University of Patras, Greece","institution_ids":["https://openalex.org/I174878644"]},{"raw_affiliation_string":"to S. S. Nikolaropoulos, Laboratory of Pharmaceutical Chemistry, School of Health Sciences, Department of Pharmacy, University of Patras, 26500 Rion (Patras), Greece","institution_ids":["https://openalex.org/I174878644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050162842","display_name":"Anna I. Koutsourea","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I174878644","display_name":"University of Patras","ror":"https://ror.org/017wvtq80","country_code":"GR","type":"education","lineage":["https://openalex.org/I174878644"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Anna I. Koutsourea","raw_affiliation_strings":["Laboratory of Pharmaceutical Chemistry, Department of Pharmacy, University of Patras, Greece","Sponsorship: This research was supported by \u2018K. Karathedori\u2019 grant 3013, Research Committee of the University of Patras, Greece","to S. S. Nikolaropoulos, Laboratory of Pharmaceutical Chemistry, School of Health Sciences, Department of Pharmacy, University of Patras, 26500 Rion (Patras), Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmaceutical Chemistry, Department of Pharmacy, University of Patras, Greece","institution_ids":["https://openalex.org/I174878644"]},{"raw_affiliation_string":"Sponsorship: This research was supported by \u2018K. Karathedori\u2019 grant 3013, Research Committee of the University of Patras, Greece","institution_ids":["https://openalex.org/I174878644"]},{"raw_affiliation_string":"to S. S. Nikolaropoulos, Laboratory of Pharmaceutical Chemistry, School of Health Sciences, Department of Pharmacy, University of Patras, 26500 Rion (Patras), Greece","institution_ids":["https://openalex.org/I174878644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112158252","display_name":"Evagelia S. Arsenou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I174878644","display_name":"University of Patras","ror":"https://ror.org/017wvtq80","country_code":"GR","type":"education","lineage":["https://openalex.org/I174878644"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Evagelia S. Arsenou","raw_affiliation_strings":["Laboratory of Pharmaceutical Chemistry, Department of Pharmacy, University of Patras, Greece","Sponsorship: This research was supported by \u2018K. Karathedori\u2019 grant 3013, Research Committee of the University of Patras, Greece","to S. S. Nikolaropoulos, Laboratory of Pharmaceutical Chemistry, School of Health Sciences, Department of Pharmacy, University of Patras, 26500 Rion (Patras), Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmaceutical Chemistry, Department of Pharmacy, University of Patras, Greece","institution_ids":["https://openalex.org/I174878644"]},{"raw_affiliation_string":"Sponsorship: This research was supported by \u2018K. Karathedori\u2019 grant 3013, Research Committee of the University of Patras, Greece","institution_ids":["https://openalex.org/I174878644"]},{"raw_affiliation_string":"to S. S. Nikolaropoulos, Laboratory of Pharmaceutical Chemistry, School of Health Sciences, Department of Pharmacy, University of Patras, 26500 Rion (Patras), Greece","institution_ids":["https://openalex.org/I174878644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003836746","display_name":"Manolis A. Fousteris","orcid":"https://orcid.org/0000-0002-1581-9145","observed_orcids":["https://orcid.org/0000-0002-1581-9145"]},"institutions":[{"id":"https://openalex.org/I174878644","display_name":"University of Patras","ror":"https://ror.org/017wvtq80","country_code":"GR","type":"education","lineage":["https://openalex.org/I174878644"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Manolis A. Fousteris","raw_affiliation_strings":["Laboratory of Pharmaceutical Chemistry, Department of Pharmacy, University of Patras, Greece","Sponsorship: This research was supported by \u2018K. Karathedori\u2019 grant 3013, Research Committee of the University of Patras, Greece","to S. S. Nikolaropoulos, Laboratory of Pharmaceutical Chemistry, School of Health Sciences, Department of Pharmacy, University of Patras, 26500 Rion (Patras), Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmaceutical Chemistry, Department of Pharmacy, University of Patras, Greece","institution_ids":["https://openalex.org/I174878644"]},{"raw_affiliation_string":"Sponsorship: This research was supported by \u2018K. Karathedori\u2019 grant 3013, Research Committee of the University of Patras, Greece","institution_ids":["https://openalex.org/I174878644"]},{"raw_affiliation_string":"to S. S. Nikolaropoulos, Laboratory of Pharmaceutical Chemistry, School of Health Sciences, Department of Pharmacy, University of Patras, 26500 Rion (Patras), Greece","institution_ids":["https://openalex.org/I174878644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075844881","display_name":"Dionysios Mourelatos","orcid":"https://orcid.org/0000-0002-3297-6257","observed_orcids":["https://orcid.org/0000-0002-3297-6257"]},"institutions":[{"id":"https://openalex.org/I174878644","display_name":"University of Patras","ror":"https://ror.org/017wvtq80","country_code":"GR","type":"education","lineage":["https://openalex.org/I174878644"]},{"id":"https://openalex.org/I21370196","display_name":"Aristotle University of Thessaloniki","ror":"https://ror.org/02j61yw88","country_code":"GR","type":"education","lineage":["https://openalex.org/I21370196"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Dionysios Mourelatos","raw_affiliation_strings":["Laboratory of Biology and Genetics, Medical School, Aristotle University, Thessaloniki, Greece","Sponsorship: This research was supported by \u2018K. Karathedori\u2019 grant 3013, Research Committee of the University of Patras, Greece","to S. S. Nikolaropoulos, Laboratory of Pharmaceutical Chemistry, School of Health Sciences, Department of Pharmacy, University of Patras, 26500 Rion (Patras), Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Biology and Genetics, Medical School, Aristotle University, Thessaloniki, Greece","institution_ids":["https://openalex.org/I21370196"]},{"raw_affiliation_string":"Sponsorship: This research was supported by \u2018K. Karathedori\u2019 grant 3013, Research Committee of the University of Patras, Greece","institution_ids":["https://openalex.org/I174878644"]},{"raw_affiliation_string":"to S. S. Nikolaropoulos, Laboratory of Pharmaceutical Chemistry, School of Health Sciences, Department of Pharmacy, University of Patras, 26500 Rion (Patras), Greece","institution_ids":["https://openalex.org/I174878644"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018215782","display_name":"Sotiris S. Nikolaropoulos","orcid":"https://orcid.org/0000-0002-3871-6886","observed_orcids":["https://orcid.org/0000-0002-3871-6886"]},"institutions":[{"id":"https://openalex.org/I174878644","display_name":"University of Patras","ror":"https://ror.org/017wvtq80","country_code":"GR","type":"education","lineage":["https://openalex.org/I174878644"]}],"countries":["GR"],"is_corresponding":true,"raw_author_name":"Sotiris S. Nikolaropoulos","raw_affiliation_strings":["Laboratory of Pharmaceutical Chemistry, Department of Pharmacy, University of Patras, Greece","Sponsorship: This research was supported by \u2018K. Karathedori\u2019 grant 3013, Research Committee of the University of Patras, Greece","to S. S. Nikolaropoulos, Laboratory of Pharmaceutical Chemistry, School of Health Sciences, Department of Pharmacy, University of Patras, 26500 Rion (Patras), Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmaceutical Chemistry, Department of Pharmacy, University of Patras, Greece","institution_ids":["https://openalex.org/I174878644"]},{"raw_affiliation_string":"Sponsorship: This research was supported by \u2018K. Karathedori\u2019 grant 3013, Research Committee of the University of Patras, Greece","institution_ids":["https://openalex.org/I174878644"]},{"raw_affiliation_string":"to S. S. Nikolaropoulos, Laboratory of Pharmaceutical Chemistry, School of Health Sciences, Department of Pharmacy, University of Patras, 26500 Rion (Patras), Greece","institution_ids":["https://openalex.org/I174878644"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5018215782"],"corresponding_institution_ids":["https://openalex.org/I174878644"],"apc_list":null,"apc_paid":null,"fwci":1.1436,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.72474092,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"16","issue":"10","first_page":"1075","last_page":"1082"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.4253000020980835,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.4253000020980835,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.24220000207424164,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12215","display_name":"Phytochemical Studies and Bioactivities","score":0.08579999953508377,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chlorambucil","display_name":"chlorambucil","score":0.7879999876022339},{"id":"https://openalex.org/keywords/bioactive-metabolites","display_name":"bioactive metabolites","score":0.5789999961853027},{"id":"https://openalex.org/keywords/d-ring-modification","display_name":"D-ring modification","score":0.8560000061988831},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8349999785423279},{"id":"https://openalex.org/keywords/antileukemic-activity","display_name":"antileukemic activity","score":0.9679999947547913},{"id":"https://openalex.org/keywords/p388-leukemia","display_name":"P388 leukemia","score":0.906000018119812},{"id":"https://openalex.org/keywords/l1210-cells","display_name":"L1210 leukemia","score":0.996999979019165},{"id":"https://openalex.org/keywords/sister-chromatid-exchange","display_name":"sister chromatid exchange","score":0.9819999933242798},{"id":"https://openalex.org/keywords/lymphocyte-proliferation-inhibition","display_name":"lymphocyte proliferation inhibition","score":0.7680000066757202},{"id":"https://openalex.org/keywords/toxicity","display_name":"toxicity","score":0.47600001096725464},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.6119999885559082}],"concepts":[{"id":"https://openalex.org/C2777866208","wikidata":"https://www.wikidata.org/wiki/Q415939","display_name":"Chlorambucil","level":4,"score":0.7541558742523193},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.7371313571929932},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6920652389526367},{"id":"https://openalex.org/C149151106","wikidata":"https://www.wikidata.org/wiki/Q4677569","display_name":"Active metabolite","level":3,"score":0.660637378692627},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.618108868598938},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.5806697607040405},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5567370653152466},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.5027267932891846},{"id":"https://openalex.org/C2780378348","wikidata":"https://www.wikidata.org/wiki/Q25351438","display_name":"Ring (chemistry)","level":2,"score":0.5020875930786133},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4953683614730835},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.4215255677700043},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3224707841873169},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.15090283751487732},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.14471852779388428},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.10087454319000244},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002699","descriptor_name":"Chlorambucil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002699","descriptor_name":"Chlorambucil","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004952","descriptor_name":"Esters","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004952","descriptor_name":"Esters","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004952","descriptor_name":"Esters","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008214","descriptor_name":"Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008815","descriptor_name":"Mice, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012854","descriptor_name":"Sister Chromatid Exchange","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013256","descriptor_name":"Steroids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013256","descriptor_name":"Steroids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013256","descriptor_name":"Steroids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00001813-200511000-00006","doi":"https://doi.org/10.1097/00001813-200511000-00006","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001813-200511000-00006","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},{"id":"pmid:16222149","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16222149","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9074000120162964,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W1489171799","https://openalex.org/W1499868135","https://openalex.org/W1939957793","https://openalex.org/W1964509310","https://openalex.org/W1969310221","https://openalex.org/W1972225016","https://openalex.org/W1981113398","https://openalex.org/W1985020750","https://openalex.org/W1990914375","https://openalex.org/W1998280747","https://openalex.org/W2005312277","https://openalex.org/W2006570699","https://openalex.org/W2008209976","https://openalex.org/W2008211855","https://openalex.org/W2033776031","https://openalex.org/W2039022474","https://openalex.org/W2044489302","https://openalex.org/W2044576697","https://openalex.org/W2059630949","https://openalex.org/W2073577901","https://openalex.org/W2078459485","https://openalex.org/W2084684525","https://openalex.org/W2086122569","https://openalex.org/W2091628251","https://openalex.org/W2093478608","https://openalex.org/W2095407348","https://openalex.org/W2105047969","https://openalex.org/W2124793163","https://openalex.org/W2134370683","https://openalex.org/W2147127715","https://openalex.org/W2157003629","https://openalex.org/W2159464078","https://openalex.org/W2321853133","https://openalex.org/W2329423403","https://openalex.org/W2400526822","https://openalex.org/W2401813517","https://openalex.org/W2414087771","https://openalex.org/W2414109487","https://openalex.org/W2462538692","https://openalex.org/W2950865428","https://openalex.org/W2952072637","https://openalex.org/W2952670656","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2094664696","https://openalex.org/W2011273038","https://openalex.org/W2008209976","https://openalex.org/W2151946683","https://openalex.org/W2462538692","https://openalex.org/W3041790145","https://openalex.org/W1985020750","https://openalex.org/W2075661422","https://openalex.org/W2029737836","https://openalex.org/W1997222331"],"abstract_inverted_index":{"We":[0],"have":[1,118],"studied":[2,31],"the":[3,8,14,38,78,82,85,92,100,109,113,119,124,134,142,145,155,165,171,174,180,183,187,199,202],"effect":[4,122],"of":[5,7,17,23,41,84,108,127,141,164,173,182,189,191,205],"modification":[6,140,172],"B-steroidal":[9,114],"ring":[10,115],"to":[11,50,57,154],"lactamic":[12],"on":[13,73,123,186],"anti-leukemic":[15,86,166],"potency":[16],"D-modified":[18],"and":[19,35,46,56],"D-non-modified":[20],"steroidal":[21,94,184,203],"esters":[22,131,157],"chlorambucil's":[24,128],"active":[25,98,129],"metabolite.":[26],"The":[27,67,106],"compounds":[28],"synthesized":[29],"were":[30],"against":[32,103],"leukemias":[33],"P388":[34],"L1210":[36],"after":[37],"subsequent":[39],"estimation":[40],"their":[42,48],"toxicity":[43],"in":[44,61,65,68,112,133],"vivo,":[45],"for":[47,179,198,219],"ability":[49],"induce":[51],"sister":[52],"chromatid":[53],"exchanges":[54],"(SCEs)":[55],"inhibit":[58],"cell":[59],"proliferation":[60],"normal":[62],"human":[63],"lymphocytes":[64],"vitro.":[66],"vitro":[69],"results":[70,79],"correlated":[71],"well,":[72],"a":[74,89,159,211],"molar":[75],"basis,":[76],"with":[77,153,158],"obtained":[80],"from":[81,170],"study":[83],"potency.":[87],"In":[88],"comparative":[90],"study,":[91],"B-lactamic":[93],"derivatives":[95,148],"proved":[96],"less":[97],"than":[99],"7-oxidized":[101],"ones":[102],"both":[104],"leukemias.":[105],"presence":[107],"-NHCO-":[110],"group":[111],"did":[116],"not":[117,209],"same":[120],"positive":[121],"biological":[125,213],"action":[126,190],"metabolite":[130],"as":[132,215],"D-lactamic":[135],"ring.":[136],"However,":[137],"this":[138],"new":[139],"B-ring":[143],"rendered":[144],"final":[146],"esteric":[147],"much":[149],"more":[150],"toxic,":[151],"compared":[152],"corresponding":[156],"simple":[160,212],"B-ring.":[161],"This":[162,195],"loss":[163],"specificity,":[167],"which":[168],"occurs":[169],"B-ring,":[175],"is":[176,208],"additional":[177],"evidence":[178],"role":[181],"part":[185,204],"mechanism":[188],"these":[192,206],"promising":[193],"compounds.":[194],"provides":[196],"support":[197],"notion":[200],"that":[201],"molecules":[207],"just":[210],"carrier,":[214],"has":[216],"been":[217],"speculated":[218],"many":[220],"years.":[221]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2003133170","counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
